Microbiotix, Merck deal

Microbiotix Inc., Worcester, Mass. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Infectious Merck granted Microbiotix exclusive, worldwide rights to two non-nucleoside HCV NS5B inhi...